CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
51 hedge funds and large institutions have $115M invested in Crescent Biopharma, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 6 closing their positions.
Holders
51
Holders Change
+3
Holders Change %
+6.25%
% of All Funds
1.28%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
10
Increased
17
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Invesco
Atlanta,
Georgia
| – | – | -129,429 | Closed |
|
52
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
| – | – | -13,800 | Closed |
|
|
CCMH
53
Cornerstone Capital Management Holdings
New York
| – | – | -1,300 | Closed |
|
54
Citigroup
New York
| $0 | 9 | -972 | -99% |
|
55
BNP Paribas Financial Markets
Paris,
France
| – | – | -751 | Closed |
|
56
Acadian Asset Management
Boston,
Massachusetts
| – | – | -541 | Closed |
|
|
AIM
57
Acrospire Investment Management
Chicago,
Illinois
| – | – | -351 | Closed |
|